Authors: Jassem, J Pienkowski, T Pluzanska, A Jelic, S Gorbunova, V Mrsic-Krmpotic, Z Berzins, J Nagykalnai, T Wigler, N Renard, J Munier, S Weil, C

Citation: J. Jassem et al., Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial, J CL ONCOL, 19(6), 2001, pp. 1707-1715